June 11, 2009 – STERIS Corp. and Siemens Medical Solutions USA Inc. announced today at the Society of Vascular Surgeons annual meeting in Denver, Colo., that they have agreed to collaborate to offer optimized vascular, cardiovascular and neurosurgical hybrid surgical suites.
 

June 11, 2009 – PETNET Solutions, a subsidiary of Siemens Medical Solutions USA Inc. that manufactures and distributes radiopharmaceuticals, has signed a supply agreement with Lantheus Medical Imaging Inc. to provide BMS747158 for PET imaging of cardiac perfusion as part of the phase II and phase III trials.


The aim of every radiation oncologist when treating a patient is to deliver radiation dose as accurately as possible. To better hit their mark, clinicians are relying increasingly on imaging to guide them to the target, which in the case of prostate cancer is often a moving target. Accordingly, the role of imaging in this year’s NCCN Prostate Cancer Guidelines was a critical component.

Molecular imaging in clinical trials accelerates the development of promising compounds by allowing physicians to see and assess whether a drug is working as intended for a patient.

Could earlier diagnosis and pre-symptomatic disease detection truly lead to disease prevention? Healthcare is on the cusp of a paradigm shift from a reactionary to a preventative approach to managing disease through diagnostic imaging and radiolabeled probes. So what is holding it back?
Benefits of early detection

New and improved techniques in magnetic resonance imaging (MRI) are popping up every day, stemming from innovations developed by physicians and manufacturers alike. Many of these new techniques are especially conducive to high-field systems — 3.0 Tesla (3T) systems and higher.

3T Advances
Greg Rose, M.D., Ph.D., president and CEO of NightRays.
The estimated time radiologists in the various subspecialties dedicate to reads.

Subspecialty radiology has been around since the ‘60s, but due to technical, political and financial barriers, it has not begun to fulfill its potential until recently.

Outcomes for the outpatient imaging industry are uncertain. The current state of the economy and the effects of the Deficit Reduction Act of 2005 (DRA), which has significantly cut Medicare reimbursement for imaging centers, are leaving outpatient-imaging centers few choices. Either they cut back and become lean, or close their doors.

June 10, 2009 – GE Healthcare will demonstrate its latest solution for the assessment of heart failure at the 20th Annual Scientific Sessions of the American Society of Echocardiography (ASE), June 7-9, in Washington, D.C.

June 10, 2009 – MDS Nordion said today it commenced the manufacture of CardioGen-82 (rubidium Rb 82 generators) for Bracco Diagnostics Inc.

MDS Nordion has designed and built a dedicated manufacturing suite within its FDA-approved, Good Manufacturing Practices-compliant production facility in Ottawa. Production of CardioGen-82 began yesterday.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now